Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study
Phase 3
- Conditions
- CataractGlaucoma
- Interventions
- Device: ologen™ Collagen Matrix Implant as an aid in phacotrabeculectomy surgery
- First Posted Date
- 2008-06-02
- Last Posted Date
- 2008-06-18
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 20
- Registration Number
- NCT00687791
- Locations
- 🇸🇬
Singapore Eye Research Institute, Singapore, Singapore
Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery
Phase 4
Completed
- Conditions
- Open Angle Glaucoma
- Interventions
- Drug: Mitomycin-C(MMC) and glaucoma filtering surgeryDevice: Collagen Matrix in Glaucoma Filtering Surgery
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2012-04-25
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 20
- Registration Number
- NCT00538590
- Locations
- 🇩🇪
Hospital of Universität Köln, Koln, Germany
Oculusgen (Ologen) Glaucoma MMC Control in Estonia
Phase 3
Completed
- Conditions
- Open Angle GlaucomaAngle Closure GlaucomaUveitis GlaucomaYoung Age GlaucomaNeovascular GlaucomaHigh Risk Patient
- Interventions
- Device: ologen (oculusgen) collagen matrix
- First Posted Date
- 2007-09-05
- Last Posted Date
- 2017-06-27
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 20
- Registration Number
- NCT00524758
- Locations
- 🇪🇪
Tartu University Clinics, Tartu, Estonia
Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital
Phase 3
- Conditions
- GlaucomasPterygium
- Interventions
- Device: ologen™ Collagen matrix implantation in glaucoma filtering surgery
- First Posted Date
- 2007-05-25
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 60
- Registration Number
- NCT00478790
- Locations
- 🇨🇳
Shanghai sixth People's Hospital, Shanghai, China
Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India
Completed
- Conditions
- CataractGlaucoma
- Interventions
- Device: OculusGen Biodegradable Collagen Matrix Implant
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 10
- Registration Number
- NCT00477685
- Locations
- 🇮🇳
Grewal Eye Institute, Chandigarh, India
Ologen (OculusGen)-Glaucoma MMC Control in Pakistan
Phase 3
Completed
- Conditions
- GlaucomaTrabeculectomy
- Interventions
- Device: ologen collagen matrix in glaucoma filtering surgery
- First Posted Date
- 2007-05-14
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00472810
- Locations
- 🇵🇰
RMC & Allied Hospital, Rawalpindi, Punjab, Pakistan
Ologen (OculusGen)-Glaucoma MMC Control Trial in India
Phase 4
- Conditions
- Glaucoma
- Interventions
- Device: OculusGen Biodegradable Collagen Matrix ImplantDrug: Trabeculectomy with MMC
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00449098
- Locations
- 🇮🇳
L. V. Prasad Eye Institute, Hyderabad, Andhra Prades, India
Ologen (OculusGen)-Glaucoma Case Control Trial in India
Phase 3
Completed
- Conditions
- Glaucoma
- Interventions
- Device: OculusGen Biodegradable Collagen Matrix Implant
- First Posted Date
- 2007-03-19
- Last Posted Date
- 2017-06-27
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00448929
- Locations
- 🇮🇳
L. V. Prasad Eye Institute, Hyderabad, Andhra Prades, India
OculusGen-Glaucoma Historical Control Study in Taiwan
Phase 3
Terminated
- Conditions
- Glaucoma
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2008-05-05
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 48
- Registration Number
- NCT00406822
- Locations
- 🇨🇳
Chang Gung Memorial Hospital -Taipei Branch, Taipei, Taiwan
Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital
Phase 3
Completed
- Conditions
- GlaucomasPterygium
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2008-05-26
- Lead Sponsor
- Pro Top & Mediking Company Limited
- Target Recruit Count
- 61
- Registration Number
- NCT00320957
- Locations
- 🇨🇳
Zhongshan Hospital Fudan University, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath